Wenhan Lin Selected Research

Wenhan Lin Research Topics

Disease

6	Neoplasms (Cancer) 01/2021 - 08/2011
6	Lymphoma (Lymphomas) 01/2021 - 08/2011
4	Ovarian Neoplasms (Ovarian Cancer) 07/2018 - 08/2011
3	Carcinoma (Carcinomatosis) 02/2019 - 03/2017
2	Obesity 05/2022 - 01/2019
2	COVID-19 03/2022 - 06/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2017
2	Human Influenza (Influenza) 01/2016 - 03/2015
1	Infections 10/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Bone Resorption 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Inflammation (Inflammations) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 06/2019
1	Body Weight (Weight, Body) 01/2019
1	Atherosclerotic Plaque (Atheroma) 11/2017
1	Atherosclerosis 11/2017
1	Glioma (Gliomas) 03/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2015
1	Wounds and Injuries (Trauma) 01/2015
1	Hepatitis C 01/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2011
1	Sarcoma (Soft Tissue Sarcoma) 01/2008
1	Chronic Pain 01/2008

Drug/Important Bio-Agent (IBA)

4	Protein Kinases (Protein Kinase)IBA 03/2017 - 08/2011
3	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2020
3	Peptide Hydrolases (Proteases)FDA Link 03/2022 - 01/2012
3	AlkaloidsIBA 06/2019 - 01/2015
2	equisetinIBA 05/2022 - 10/2021
2	EnzymesIBA 05/2022 - 01/2021
2	Anti-Allergic Agents (Antiallergic Agents)IBA 03/2022 - 06/2021
2	Pharmaceutical PreparationsIBA 06/2021 - 01/2016
2	asperlinIBA 01/2019 - 11/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 08/2011
1	Oxidoreductases (Dehydrogenase)IBA 05/2022
1	Colistin (Coly-Mycin)FDA Link 10/2021
1	Pancreatic Elastase (Elastase)IBA 06/2021
1	butyrolactone IIBA 06/2021
1	Cyclin-Dependent Kinase 2IBA 01/2021
1	tartaric acid (tartrate)FDA Link 01/2021
1	Matrix Metalloproteinase 13IBA 01/2021
1	sulochrinIBA 01/2021
1	Acid PhosphataseIBA 01/2021
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	AcetylcholinesteraseIBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2019
1	ochratoxin BIBA 02/2019
1	viomelleinIBA 02/2019
1	PolyketidesIBA 10/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2018
1	pyrrocidine AIBA 07/2018
1	penicolinate AIBA 01/2018
1	butenolideIBA 11/2017
1	Apolipoproteins E (ApoE)IBA 11/2017
1	ErbB Receptors (EGF Receptor)IBA 03/2017
1	rhodoptilometrinIBA 03/2017
1	1'-deoxyrhodoptilometrinIBA 03/2017
1	AnthraquinonesIBA 03/2017
1	Phosphotransferases (Kinase)IBA 03/2017
1	Focal Adhesion Protein-Tyrosine KinasesIBA 03/2017
1	spiromastilactone DIBA 01/2016
1	DiterpenesIBA 12/2015
1	W493 AIBA 10/2015
1	AcidsIBA 09/2015
1	4-dehydroxyaltersolanol AIBA 09/2015
1	DiketopiperazinesIBA 03/2015
1	Hemagglutinins (Hemagglutinin)IBA 03/2015
1	neoechinulinIBA 03/2015
1	sialic acid receptorIBA 03/2015
1	indoleIBA 03/2015
1	Cytostatic AgentsIBA 01/2014
1	lobocrasolIBA 08/2013
1	sesquibastadinIBA 01/2013
1	PolyphenolsIBA 01/2012
1	RNA (Ribonucleic Acid)IBA 01/2012
1	TrabectedinIBA 01/2008
1	ziconotide (Prialt)FDA Link 01/2008
1	Analgesics (Analgesic Drugs)IBA 01/2008
1	Antineoplastic Agents (Antineoplastics)IBA 01/2008

Therapy/Procedure

2	Oral Administration 01/2019 - 11/2017
1	Therapeutics 01/2020
1	Drug Therapy (Chemotherapy) 01/2015